Abstract P253: Potent and selective AXL tyrosine kinase inhibition demonstrates significant anti-tumor efficacy in combination with standard of care therapeutics in preclinical models

2021 ◽  
Author(s):  
Susan L. Paprcka ◽  
Subhasree Sridhar ◽  
Irene M. Luu ◽  
Salema Jafri ◽  
Dillon H. Miles ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Standard Of Care ◽  
Preclinical Models ◽  
Kinase Inhibition ◽  
Tyrosine Kinase Inhibition

scholarly journals Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats

2004 ◽  
Vol 66 (5) ◽  
pp. 1766-1773 ◽  
Author(s):  
Vicente E. Torres ◽  
William E. Sweeney ◽  
Xiaofang Wang ◽  
Q.I. Qian ◽  
Peter C. Harris ◽  
...  
Keyword(s):  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Tyrosine Kinase ◽  
Receptor Tyrosine Kinase ◽  
Growth Factor Receptor ◽  
Kinase Inhibition ◽  
Tyrosine Kinase Inhibition ◽  
Epidermal Growth

scholarly journals Correction: Cytotoxic trichothecene-type sesquiterpenes from the sponge-derived fungus Stachybotrys chartarum with tyrosine kinase inhibition

RSC Advances ◽  
2019 ◽  
Vol 9 (37) ◽  
pp. 21518-21518
Author(s):  
Yong Li ◽  
Dong Liu ◽  
Zhongbin Cheng ◽  
Peter Proksch ◽  
Wenhan Lin
Keyword(s):  
Tyrosine Kinase ◽  
Stachybotrys Chartarum ◽  
Kinase Inhibition ◽  
Tyrosine Kinase Inhibition

Correction for ‘Cytotoxic trichothecene-type sesquiterpenes from the sponge-derived fungus Stachybotrys chartarum with tyrosine kinase inhibition’ by Yong Li et al., RSC Adv., 2017, 7, 7259–7267.

Sign in / Sign up

Export Citation Format

Share Document